BCTX BriaCell Therapeutics Corp.

BriaCell is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer.

$6.23  +0.62 (11.05%)
As of 06/24/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Canada
Country of incorporation:  
IPO date:  10/28/2010
Outstanding shares:  15,279,276
Average volume:  472,114
Market cap:   $85,716,738
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   2.08
PS ratio:   0.00
Return on equity:   -11.22%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy